Hrt Financial LP Kala Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $11.7 $5,970 - $279,396	-23,880 Reduced 61.32%	15,064 $3,000
Q2 2022 Aug 12, 2022	BUY	$0.3 - $1.31 $11,683 - $51,016	38,944 New	38,944 $11,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $26,264 - $79,224	-43,057 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $49,946 - $117,976	43,057 New	43,057 $52,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $330,246 - $462,239	-52,587 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.5 - $11.11 $394,402 - $584,241	52,587 New	52,587 $394,000
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $62,766 - $144,050	-16,388 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $55,063 - $78,826	16,388 New	16,388 $60,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.